Skip to content
Contact Us
KCAS Blog
Careers
Menu Toggle
Why a Career at KCAS
Roles We Hire
Menu Toggle
Scientist Jobs
Business Jobs
New Grads
How You’ll Benefit
Search for:
Home
ABOUT
Menu Toggle
Why KCAS?
Leadership Team
Quality Assurance
Client Testimonials
SOLUTIONS
Menu Toggle
BIOMARKERS
Menu Toggle
Exploratory
Regulated CTA (Clinical Trial Application)
Non-Reg CTA (Clinical Trial Application)
MOLECULE TYPE
Menu Toggle
Small Molecule
Large Molecule
Cell & Gene Therapy
Other (Mixed-Mode Macro-Molecules)
RESEARCH PHASE
Menu Toggle
Early Research
Discovery
Pre-Clinical
Clinical Development
Manufacturing & Commercialization
Therapeutic Area
Menu Toggle
Autoimmune and Immunological
Cancer/Oncology
Cardiovascular & Metabolic
Gastrointestinal
Neurological Disorders
Ophthalmology
Orphan/Rare Diseases
Respiratory
Renal (kidney)
Infectious Diseases & Vaccines
Platforms
Menu Toggle
ELISA
ELISpot
Flow Cytometry
Hybrid LC-MS/MS
LC-MS/MS
Ligand Binding Assays
Meso Scale Discovery (ECL)
LC-UV/Fluorescence
Luminex
Quantitative PCR (qPCR and ddPCR)
IsoPlexis
News & Events
Menu Toggle
Upcoming Events
News
Resources
Menu Toggle
Compound Classes
Posters & White Papers
Info Sheets
Main Menu
LC-MS/MS
KCAS has established a wide range of assays in various biological matrices.
The methods tabulated below vary from Qualified to Fully Validated Methods.
Assay Search
Ibuprofen
Matrix:
Human Plasma
LLOQ:
25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Imipramine / Desipramine
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Indomethacin
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Isotretinoin / 4-Oxo-Isotretinoin
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Isradapine
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/mL
Platform:Â
LC-MS/MS
Ketoconazole / Clotrimazole
Matrix:
Human Plasma
LLOQ:
50 / 5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Ketoprofen
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Levofloxacin
Matrix:
Rabbit Plasma
LLOQ:
0.2
Unit:
mcg/mL
Platform:Â
LC-MS/MS
Lidocaine
Matrix:
Dog Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Lidocaine
Matrix:
Dog Urine
LLOQ:
0.1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Lidocaine
Matrix:
Dog Tissue
LLOQ:
10
Unit:
ng/g
Platform:Â
LC-MS/MS
Lidocaine
Matrix:
Rat Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Lorazepam
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Losartan / Carboxylosartan
Matrix:
Human Plasma
LLOQ:
2 / 2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Meloxicam
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Memantine
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Memantine N-Glucuronide
Matrix:
Human Plasma
LLOQ:
0.2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Mephenytoin, (R)- / Mephenytoin, (S)-
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Mephenytoin, (R)- / Mephenytoin, (S)-
Matrix:
Human Saliva
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Mephenytoin, (R)- / Mephenytoin, (S)-
Matrix:
Human Urine
LLOQ:
0.1
Unit:
mcg/mL
Platform:Â
LC-MS/MS
Mephenytoin, (R)- / Mephenytoin, (S)-
Matrix:
Human Urine
LLOQ:
0.1
Unit:
mcg/mL
Platform:Â
LC-MS/MS
Mercaptopurine, 6- / 6-Thiouric Acid
Matrix:
Human Plasma
LLOQ:
2 / 20
Unit:
ng/mL
Platform:Â
LC-MS/MS
Mercaptopurine, 6- / 6-Thiouric Acid
Matrix:
Human Urine
LLOQ:
6 / 60
Unit:
ng/mL
Platform:Â
LC-MS/MS
Metformin
Matrix:
Human Plasma
LLOQ:
20
Unit:
ng/mL
Platform:Â
LC-MS/MS
Methylnicotinamide
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Methylnicotinamide
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Methylphenidate
Matrix:
Human Plasma
LLOQ:
100
Unit:
pg/ml
Platform:Â
LC-MS/MS
Methylprednisolone
Matrix:
Human Plasma
LLOQ:
2.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Metoprolol
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Midazolam / 1-Hydroxymidazolam / 4-Hydroxymidazolam
Matrix:
Human Urine
LLOQ:
10 / 2 / 2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Midazolam / a-Hydroxymidazolam
Matrix:
Human Urine
LLOQ:
20 / 0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Molindone
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Morphine / Morphine-3-Glucuronide / Morpine-6-Glucuronide
Matrix:
Dog Plasma
LLOQ:
0.5 / 5 / 2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Morphine / Morphine-3-Glucuronide / Morpine-6-Glucuronide
Matrix:
Human Plasma
LLOQ:
0.5 / 5 / 2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Morphine / Morphine-3-Glucuronide / Morpine-6-Glucuronide
Matrix:
Ovine Plasma
LLOQ:
0.5 / 5 / 2
Unit:
ng/mL
Platform:Â
LC-MS/MS
Moxifloxacin
Matrix:
Human DBS
LLOQ:
100
Unit:
ng/mL
Platform:Â
LC-MS/MS
Moxifloxacin
Matrix:
Human Plasma
LLOQ:
20
Unit:
ng/mL
Platform:Â
LC-MS/MS
Niacin (Nicotinic Acid) / Nicotinuric Acid
Matrix:
Human Urine
LLOQ:
25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Nifedipine / NPO
Matrix:
Human Plasma
LLOQ:
1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Noroxycodone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Olanzapine
Matrix:
Human Plasma
LLOQ:
0.1
Unit:
ng/mL
Platform:Â
LC-MS/MS
Omeprazole
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Ondansetron
Matrix:
Human Plasma
LLOQ:
0.5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Oxandrolone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Oxybutynin / N-Desethyloxybutynin
Matrix:
Human Plasma
LLOQ:
0.0500 / 0.25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Oxycodone / Noroxycodcone / Oxymorphone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Oxymorphone
Matrix:
Human Plasma
LLOQ:
0.25
Unit:
ng/mL
Platform:Â
LC-MS/MS
Paclitaxel
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
Paclitaxel
Matrix:
Human Urine
LLOQ:
5
Unit:
ng/mL
Platform:Â
LC-MS/MS
Pantoprazole
Matrix:
Human Plasma
LLOQ:
10
Unit:
ng/mL
Platform:Â
LC-MS/MS
First
Previous
1
2
3
4
Next
Last
Posts navigation
←
Previous Page
1
2
3
4
Next Page
→
Search for:
Contact Us
KCAS Blog
Careers
Menu Toggle
Why a Career at KCAS
Roles We Hire
Menu Toggle
Scientist Jobs
Business Jobs
New Grads
How You’ll Benefit
Home
ABOUT
Menu Toggle
Why KCAS?
Leadership Team
Quality Assurance
Client Testimonials
SOLUTIONS
Menu Toggle
BIOMARKERS
Menu Toggle
Exploratory
Regulated CTA (Clinical Trial Application)
Non-Reg CTA (Clinical Trial Application)
MOLECULE TYPE
Menu Toggle
Small Molecule
Large Molecule
Cell & Gene Therapy
Other (Mixed-Mode Macro-Molecules)
RESEARCH PHASE
Menu Toggle
Early Research
Discovery
Pre-Clinical
Clinical Development
Manufacturing & Commercialization
Therapeutic Area
Menu Toggle
Autoimmune and Immunological
Cancer/Oncology
Cardiovascular & Metabolic
Gastrointestinal
Neurological Disorders
Ophthalmology
Orphan/Rare Diseases
Respiratory
Renal (kidney)
Infectious Diseases & Vaccines
Platforms
Menu Toggle
ELISA
ELISpot
Flow Cytometry
Hybrid LC-MS/MS
LC-MS/MS
Ligand Binding Assays
Meso Scale Discovery (ECL)
LC-UV/Fluorescence
Luminex
Quantitative PCR (qPCR and ddPCR)
IsoPlexis
News & Events
Menu Toggle
Upcoming Events
News
Resources
Menu Toggle
Compound Classes
Posters & White Papers
Info Sheets
Contact Us
KCAS Blog
Careers
Menu Toggle
Why a Career at KCAS
Roles We Hire
Menu Toggle
Scientist Jobs
Business Jobs
New Grads
How You’ll Benefit
Scroll to Top